Entheon Biomedical Corp. (ENTBF)
OTCMKTS · Delayed Price · Currency is USD
0.0790
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST

Entheon Biomedical Statistics

Total Valuation

ENTBF has a market cap or net worth of 1.01 million. The enterprise value is 729,309.

Market Cap1.01M
Enterprise Value 729,309

Important Dates

The next estimated earnings date is Thursday, March 5, 2026.

Earnings Date Mar 5, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 13.86M
Shares Outstanding n/a
Shares Change (YoY) +73.57%
Shares Change (QoQ) n/a
Owned by Insiders (%) 2.91%
Owned by Institutions (%) n/a
Float 13.46M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 3.56
P/TBV Ratio 3.56
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -2.92
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 21.84

Current Ratio 21.84
Quick Ratio 21.16
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -110.91% and return on invested capital (ROIC) is -71.40%.

Return on Equity (ROE) -110.91%
Return on Assets (ROA) -67.20%
Return on Invested Capital (ROIC) -71.40%
Return on Capital Employed (ROCE) -90.77%
Weighted Average Cost of Capital (WACC) 12.35%
Revenue Per Employee n/a
Profits Per Employee -249,530
Employee Count1
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -29.84% in the last 52 weeks. The beta is 1.47, so ENTBF's price volatility has been higher than the market average.

Beta (5Y) 1.47
52-Week Price Change -29.84%
50-Day Moving Average 0.07
200-Day Moving Average 0.09
Relative Strength Index (RSI) 53.20
Average Volume (20 Days) 2,226

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -257,032
Pretax Income -249,530
Net Income -249,530
EBITDA n/a
EBIT -257,032
Earnings Per Share (EPS) -0.02
Full Income Statement

Balance Sheet

The company has 278,214 in cash and n/a in debt, with a net cash position of 278,214.

Cash & Cash Equivalents 278,214
Total Debt n/a
Net Cash 278,214
Net Cash Per Share n/a
Equity (Book Value) 283,184
Book Value Per Share 0.02
Working Capital 279,544
Full Balance Sheet

Cash Flow

Operating Cash Flow -252,139
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ENTBF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -73.57%
Shareholder Yield -73.57%
Earnings Yield -24.78%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on March 1, 2024. It was a reverse split with a ratio of 0.1.

Last Split Date Mar 1, 2024
Split Type Reverse
Split Ratio 0.1

Scores

Altman Z-Score n/a
Piotroski F-Score 1